TTC19

tetratricopeptide repeat domain 19, the group of Mitochondrial respiratory chain complex assembly factors|Tetratricopeptide repeat domain containing

Basic information

Region (hg38): 17:15999784-16045015

Links

ENSG00000011295NCBI:54902OMIM:613814HGNC:26006Uniprot:Q6DKK2AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • mitochondrial complex III deficiency nuclear type 2 (Strong), mode of inheritance: AR
  • mitochondrial complex III deficiency nuclear type 2 (Strong), mode of inheritance: AR
  • mitochondrial complex III deficiency (Supportive), mode of inheritance: AR
  • mitochondrial complex III deficiency nuclear type 2 (Moderate), mode of inheritance: AR
  • Leigh syndrome (Definitive), mode of inheritance: AR
  • mitochondrial complex III deficiency nuclear type 2 (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Mitochondrial complex III deficiency, nuclear type 2ARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingBiochemical; Musculoskeletal; Neurologic21278747; 23532514; 24368687; 24397319
Individuals may suffer acute episodes of metabolic crisis; Treatment with Mitochondrial cocktail type therapy may be beneficial

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the TTC19 gene.

  • not_provided (166 variants)
  • Inborn_genetic_diseases (70 variants)
  • Mitochondrial_complex_III_deficiency_nuclear_type_2 (52 variants)
  • not_specified (18 variants)
  • TTC19-related_disorder (7 variants)
  • Mitochondrial_disease (2 variants)
  • Autism (1 variants)
  • Mitochondrial_complex_III_deficiency_nuclear_type_1 (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the TTC19 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000017775.4. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
3
clinvar
40
clinvar
1
clinvar
44
missense
2
clinvar
93
clinvar
15
clinvar
110
nonsense
9
clinvar
2
clinvar
2
clinvar
13
start loss
1
1
frameshift
3
clinvar
2
clinvar
1
clinvar
1
clinvar
7
splice donor/acceptor (+/-2bp)
1
clinvar
8
clinvar
1
clinvar
10
Total 13 15 100 55 2

Highest pathogenic variant AF is 0.0000818457

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
TTC19protein_codingprotein_codingENST00000261647 1045636
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.38e-80.59412562101271257480.000505
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.08271761790.9830.000008802434
Missense in Polyphen5156.3650.90482761
Synonymous-1.217966.41.190.00000331745
Loss of Function1.161520.70.7259.77e-7251

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0007350.000735
Ashkenazi Jewish0.00009920.0000992
East Asian0.0003810.000381
Finnish0.0002310.000231
European (Non-Finnish)0.0007660.000765
Middle Eastern0.0003810.000381
South Asian0.0001310.000131
Other0.0001630.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Required for the preservation of the structural and functional integrity of mitochondrial respiratory complex III by allowing the physiological turnover of the Rieske protein UQCRFS1 (PubMed:21278747, PubMed:28673544). Involved in the clearance of UQCRFS1 N-terminal fragments, which are produced upon incorporation of UQCRFS1 into the complex III and whose presence is detrimental for its catalytic activity (PubMed:28673544). {ECO:0000269|PubMed:21278747, ECO:0000269|PubMed:28673544}.;
Disease
DISEASE: Mitochondrial complex III deficiency, nuclear 2 (MC3DN2) [MIM:615157]: A disorder of the mitochondrial respiratory chain resulting in a highly variable phenotype depending on which tissues are affected. Clinical features include mitochondrial encephalopathy, psychomotor retardation, ataxia, severe failure to thrive, liver dysfunction, renal tubulopathy, muscle weakness and exercise intolerance. {ECO:0000269|PubMed:21278747}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.0786

Haploinsufficiency Scores

pHI
0.255
hipred
N
hipred_score
0.144
ghis
0.413

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
gene_indispensability_pred
N
gene_indispensability_score
0.0761

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Ttc19
Phenotype

Gene ontology

Biological process
mitotic cytokinesis;mitochondrial respiratory chain complex III assembly;oxidation-reduction process
Cellular component
mitochondrion;mitochondrial inner membrane;centrosome;midbody;respirasome
Molecular function
protein binding